These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 35307002)

  • 21. Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives.
    Barone M; D'Amico F; Fabbrini M; Rampelli S; Brigidi P; Turroni S
    World J Gastroenterol; 2021 Nov; 27(41):7041-7064. PubMed ID: 34887627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
    Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Methods for Gut Microbiota Modification in Lipopolysaccharide-Associated Encephalopathy.
    Li S; Guo H; Xu X; Hua R; Zhao Q; Li J; Lv J; Li J
    Shock; 2021 Nov; 56(5):824-831. PubMed ID: 33595259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
    Huda MN; Kim M; Bennett BJ
    Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota.
    Flaig B; Garza R; Singh B; Hamamah S; Covasa M
    Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota and old age: Modulating factors and interventions for healthy longevity.
    Coman V; Vodnar DC
    Exp Gerontol; 2020 Nov; 141():111095. PubMed ID: 32979504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updates.
    Shukla V; Singh S; Verma S; Verma S; Rizvi AA; Abbas M
    Clin Nutr ESPEN; 2024 Oct; 63():813-820. PubMed ID: 39178987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiota medicine: towards clinical revolution.
    Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
    J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
    Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
    Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?
    Mehmood K; Moin A; Hussain T; Rizvi SMD; Gowda DV; Shakil S; Kamal MA
    Folia Microbiol (Praha); 2021 Dec; 66(6):897-916. PubMed ID: 34699042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
    Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
    EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the gut microbiota in cancer cachexia.
    Rocha IM; Fonseca DC; Torrinhas RSM; Waitzberg DL
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):482-489. PubMed ID: 37389459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the Gut Microbiome to Treat Cardiometabolic Disease.
    Theofilis P; Vlachakis PK; Oikonomou E; Tsioufis K; Tousoulis D
    Curr Atheroscler Rep; 2024 Feb; 26(2):25-34. PubMed ID: 38180642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.